Search

Your search keyword '"Anne Juuti"' showing total 62 results

Search Constraints

Start Over You searched for: Author "Anne Juuti" Remove constraint Author: "Anne Juuti"
62 results on '"Anne Juuti"'

Search Results

1. Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis

2. Computational modelling of self-reported dietary carbohydrate intake on glucose concentrations in patients undergoing Roux-en-Y gastric bypass versus one-anastomosis gastric bypass

3. Prospective randomized controlled trial comparing the efficacy and safety of Roux-en-Y gastric bypass and one-anastomosis gastric bypass (the RYSA trial): trial protocol and interim analysis

4. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

5. OSBP-related proteins (ORPs) in human adipose depots and cultured adipocytes: evidence for impacts on the adipocyte phenotype.

11. Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis

12. Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease

13. The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particles

14. Defining Global Benchmarks in Elective Secondary Bariatric Surgery Comprising Conversional, Revisional, and Reversal Procedures

15. Women's Reasons to Seek Bariatric Surgery and Their Expectations on the Surgery Outcome - a Multicenter Study from Five European Countries

16. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

17. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease

18. Bile Reflux is a Common Finding in the Gastric Pouch After One Anastomosis Gastric Bypass

19. Notum produced by Paneth cells attenuates regeneration of aged intestinal epithelium

21. Fetal-like reversion in the regenerating intestine is regulated by mesenchymal Asporin

22. Defining global benchmarks in elective secondary bariatric surgery comprising conversional, revisional and reversal procedures

23. Käypä hoito -suosituksen fibroosilaskureiden toimivuus lihavien rasvamaksatautipotilaiden edenneen fibroosin selvittelyssä

24. The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients

25. Computational modelling of self-reported dietary carbohydrate intake on glucose concentrations in patients undergoing Roux-en-Y gastric bypass versus one-anastomosis gastric bypass

26. The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue

27. Errors-in-Variables Modeling of Personalized Treatment-Response Trajectories

28. MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans

29. Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD

30. Paneth cell produced Notum attenuates regeneration of aged intestinal epithelium

31. Prospective randomized controlled trial comparing the efficacy and safety of Roux-en-Y gastric bypass and one-anastomosis gastric bypass (the RYSA trial): trial protocol and interim analysis

32. Long-term outcome after sequential liver and lung metastasectomy is comparable to outcome of isolated liver or lung metastasectomy in colorectal carcinoma

33. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity

34. Is preoperative gastroscopy necessary before sleeve gastrectomy and Roux-en-Y gastric bypass?

35. A Retrospective 2-Year Follow-up of Late Complications Treated Surgically and Endoscopically After Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) and Laparoscopic Sleeve Gastrectomy (LSG) for Morbid Obesity

36. Bile Reflux Scintigraphy After Mini-Gastric Bypass

37. A population-based study on the prevalence of NASH using scores validated against liver histology

38. Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: A prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up

39. Long-Term Effect of Gastric Bypass and Sleeve Gastrectomy on Severe Obesity : Do Preoperative Weight Loss and Binge Eating Behavior Predict the Outcome of Bariatric Surgery?

40. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience

41. SLEEVEPASS: A randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results

42. Preoperative Transabdominal Ultrasonography (US) Prior to Laparoscopic Roux-en-Y Gastric Bypass (LRYGBP) and Laparoscopic Sleeve Gastrectomy (LSG) in the First 100 Operations. Was It Beneficial and Reliable During the Learning Curve?

43. Laparoscopic Sleeve Gastrectomy in Patients over 59 Years: Early Recovery and 12-Month Follow-Up

44. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity

45. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma

46. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer

47. Epithelial MMP-2 Expression Correlates with Worse Prognosis in Pancreatic Cancer

48. Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation

49. [The effect of gastric sleeve and bypass surgery on the use and costs of medications for type 2 diabetes]

50. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids

Catalog

Books, media, physical & digital resources